IRIS Accounts Production v23.3.1.45 10601274 Board of Directors 1.3.22 28.2.23 28.2.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh106012742022-02-28106012742023-02-28106012742022-03-012023-02-28106012742021-02-28106012742021-03-012022-02-28106012742022-02-2810601274ns10:Originalns15:EnglandWales2022-03-012023-02-2810601274ns14:PoundSterlingns10:Original2022-03-012023-02-2810601274ns10:Originalns10:Director12022-03-012023-02-2810601274ns10:Original2022-03-012023-02-2810601274ns10:Original2023-02-2810601274ns10:Originalns10:PrivateLimitedCompanyLtd2022-03-012023-02-2810601274ns10:Originalns10:SmallEntities2022-03-012023-02-2810601274ns10:Originalns10:AuditExempt-NoAccountantsReport2022-03-012023-02-2810601274ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-03-012023-02-2810601274ns10:SmallCompaniesRegimeForAccountsns10:Original2022-03-012023-02-2810601274ns10:Originalns10:AbridgedAccounts2022-03-012023-02-2810601274ns10:Original12022-03-012023-02-2810601274ns10:Originalns10:Director22022-03-012023-02-2810601274ns10:Originalns10:RegisteredOffice2022-03-012023-02-2810601274ns10:Original2022-02-2810601274ns10:Originalns5:CurrentFinancialInstruments2023-02-2810601274ns10:Originalns5:CurrentFinancialInstruments2022-02-2810601274ns10:Originalns5:Non-currentFinancialInstruments2023-02-2810601274ns10:Originalns5:Non-currentFinancialInstruments2022-02-2810601274ns5:ShareCapitalns10:Original2023-02-2810601274ns5:ShareCapitalns10:Original2022-02-2810601274ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-02-2810601274ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-02-2810601274ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-03-012023-02-2810601274ns10:Originalns5:ComputerSoftware2022-03-012023-02-2810601274ns10:Original2021-03-012022-02-2810601274ns10:Original2022-02-2810601274ns10:Original1ns10:Director12022-02-2810601274ns10:Original1ns10:Director12021-02-2810601274ns10:Original1ns10:Director12022-03-012023-02-2810601274ns10:Original1ns10:Director12021-03-012022-02-2810601274ns10:Original1ns10:Director12023-02-2810601274ns10:Original1ns10:Director12022-02-28
REGISTERED NUMBER: 10601274 (England and Wales)















Unaudited Financial Statements for the Year Ended 28 February 2023

for

Surecare Newcastle Limited

Surecare Newcastle Limited (Registered number: 10601274)






Contents of the Financial Statements
for the Year Ended 28 February 2023




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


Surecare Newcastle Limited

Company Information
for the Year Ended 28 February 2023







DIRECTORS: M Duggal
A Duggal





REGISTERED OFFICE: The Grainger Suite Regent Centre
Gosforth
Newcastle Upon Tyne
NE3 3PF





REGISTERED NUMBER: 10601274 (England and Wales)





ACCOUNTANTS: Flannagans Chartered Certified - Hartlepool office
3A Evolution
Wynyard Business Park
Wynyard
TS22 5TB

Surecare Newcastle Limited (Registered number: 10601274)

Abridged Balance Sheet
28 February 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - 118
Tangible assets 5 838 1,161
838 1,279

CURRENT ASSETS
Debtors 298,152 170,893
Cash at bank and in hand 15,164 23,969
313,316 194,862
CREDITORS
Amounts falling due within one year 219,572 129,282
NET CURRENT ASSETS 93,744 65,580
TOTAL ASSETS LESS CURRENT
LIABILITIES

94,582

66,859

CREDITORS
Amounts falling due after more than one year 6 22,469 42,498
NET ASSETS 72,113 24,361

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 72,013 24,261
72,113 24,361

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Surecare Newcastle Limited (Registered number: 10601274)

Abridged Balance Sheet - continued
28 February 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 28 February 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 November 2023 and were signed on its behalf by:





M Duggal - Director


Surecare Newcastle Limited (Registered number: 10601274)

Notes to the Financial Statements
for the Year Ended 28 February 2023

1. STATUTORY INFORMATION

Surecare Newcastle Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Surecare Newcastle Limited (Registered number: 10601274)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 63 (2022 - 67 ) .

4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 March 2022
and 28 February 2023 39,664
AMORTISATION
At 1 March 2022 39,546
Amortisation for year 118
At 28 February 2023 39,664
NET BOOK VALUE

At 28 February 2023 -
At 28 February 2022 118

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 March 2022 5,711
Additions 784
At 28 February 2023 6,495
DEPRECIATION
At 1 March 2022 4,550
Charge for year 1,107
At 28 February 2023 5,657
NET BOOK VALUE
At 28 February 2023 838
At 28 February 2022 1,161

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN FIVE
YEARS
2023 2022
£    £   
Repayable by instalments
Bank loans more 5 yr by instal 22,469 32,252

Surecare Newcastle Limited (Registered number: 10601274)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2023

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28 February 2023 and 28 February 2022:

2023 2022
£    £   
M Duggal
Balance outstanding at start of year 73,589 (4,000 )
Amounts advanced - 77,589
Amounts repaid (74,000 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (411 ) 73,589